Literature DB >> 26306884

Ketosis may promote brain macroautophagy by activating Sirt1 and hypoxia-inducible factor-1.

Mark F McCarty1, James J DiNicolantonio2, James H O'Keefe2.   

Abstract

Ketogenic diets are markedly neuroprotective, but the basis of this effect is still poorly understood. Recent studies demonstrate that ketone bodies increase neuronal levels of hypoxia-inducible factor-1α (HIF-1α), possibly owing to succinate-mediated inhibition of prolyl hydroxylase activity. Moreover, there is reason to suspect that ketones can activate Sirt1 in neurons, in part by increasing cytoplasmic and nuclear levels of Sirt1's obligate cofactor NAD(+). Another recent study has observed reduced activity of mTORC1 in the hippocampus of rats fed a ketogenic diet - an effect plausibly attributable to Sirt1 activation. Increased activities of HIF-1 and Sirt1, and a decrease in mTORC1 activity, could be expected to collaborate in the induction of neuronal macroautophagy. Considerable evidence points to moderate up-regulation of neuronal autophagy as a rational strategy for prevention of neurodegenerative disorders; elimination of damaged mitochondria that overproduce superoxide, as well as clearance of protein aggregates that mediate neurodegeneration, presumably contribute to this protection. Hence, autophagy may mediate some of the neuroprotective benefits of ketogenic diets. Brain-permeable agents which activate AMP-activated kinase, such as metformin and berberine, as well as the Sirt1 activator nicotinamide riboside, can also boost neuronal autophagy, and may have potential for amplifying the impact of ketogenesis on this process. Since it might not be practical for most people to adhere to ketogenic diets continuously, alternative strategies are needed to harness the brain-protective potential of ketone bodies. These may include ingestion of medium-chain triglycerides or coconut oil, intermittent ketogenic dieting, and possibly the use of supplements that promote hepatic ketogenesis - notably carnitine and hydroxycitrate - in conjunction with dietary regimens characterized by long daily episodes of fasting or carbohydrate avoidance.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26306884     DOI: 10.1016/j.mehy.2015.08.002

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  18 in total

1.  The Antidiabetic Drug Metformin Stimulates Glycolytic Lactate Production in Cultured Primary Rat Astrocytes.

Authors:  Adrian Westhaus; Eva Maria Blumrich; Ralf Dringen
Journal:  Neurochem Res       Date:  2015-10-03       Impact factor: 3.996

Review 2.  Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance.

Authors:  Sophia M Raefsky; Mark P Mattson
Journal:  Free Radic Biol Med       Date:  2016-11-29       Impact factor: 7.376

Review 3.  Potentials of ketogenic diet against chronic kidney diseases: pharmacological insights and therapeutic prospects.

Authors:  Sushmita Kundu; Khandkar Shaharina Hossain; Akhi Moni; Md Sarwar Zahan; Md Masudur Rahman; Md Jamal Uddin
Journal:  Mol Biol Rep       Date:  2022-04-20       Impact factor: 2.742

Review 4.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

5.  Precision Nutrition for Alzheimer's Prevention in ApoE4 Carriers.

Authors:  Nicholas G Norwitz; Nabeel Saif; Ingrid Estrada Ariza; Richard S Isaacson
Journal:  Nutrients       Date:  2021-04-19       Impact factor: 5.717

Review 6.  Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing.

Authors:  Stephen C Cunnane; Mark J Millan; Eugenia Trushina; Cecilie Morland; Alessandro Prigione; Gemma Casadesus; Zane B Andrews; M Flint Beal; Linda H Bergersen; Roberta D Brinton; Suzanne de la Monte; Anne Eckert; Jenni Harvey; Ross Jeggo; Jack H Jhamandas; Oliver Kann; Clothide Mannoury la Cour; William F Martin; Gilles Mithieux; Paula I Moreira; Michael P Murphy; Klaus-Armin Nave; Tal Nuriel; Stéphane H R Oliet; Frédéric Saudou; Mark P Mattson; Russell H Swerdlow
Journal:  Nat Rev Drug Discov       Date:  2020-07-24       Impact factor: 84.694

7.  miR-29b overexpression induces cochlear hair cell apoptosis through the regulation of SIRT1/PGC-1α signaling: Implications for age-related hearing loss.

Authors:  Tao Xue; Li Wei; Ding-Jun Zha; Jian-Hua Qiu; Fu-Quan Chen; Li Qiao; Yang Qiu
Journal:  Int J Mol Med       Date:  2016-09-14       Impact factor: 4.101

8.  Induced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought?

Authors:  Gerwyn Morris; Basant K Puri; Andre Carvalho; Michael Maes; Michael Berk; Anu Ruusunen; Lisa Olive
Journal:  Int J Neuropsychopharmacol       Date:  2020-06-24       Impact factor: 5.176

9.  [Expression and correlation analysis of hypoxia inducible factor 1α and autophagy related molecules in rat nucleus pulposus cells under hypoxia].

Authors:  Ao Cheng; Pengjie He; Junyu Zhang; Weiwei Zheng; Min Yang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-03-15

Review 10.  Beneficial Effects of Exogenous Ketogenic Supplements on Aging Processes and Age-Related Neurodegenerative Diseases.

Authors:  Zsolt Kovács; Brigitta Brunner; Csilla Ari
Journal:  Nutrients       Date:  2021-06-26       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.